How surgery startups trap patients

A mix of fear and urgency has made it easy for online health companies to convince people to undergo surgeries.

28 July, 202210 min
0
How surgery startups trap patients

Why read this story?

Editor's note: Last year, after experiencing acute pain in his lower back and frequent constipation for two months, M, a 35-year-old corporate executive, decided to enquire about treatment on Gurugram-based online healthcare platform Pristyn Care. The process was straightforward. He clicked on “Piles” and a list of proctologists in his city appeared. M chose the doctor with the highest rating and requested a callback. Half an hour later, he received a call, from a sales representative and not a doctor, as he was expecting. Apart from providing his age and other basic information, M mentioned that he’d had nothing more than a basic diagnosis of haemorrhoids. At this, the Pristyn Care representative suddenly seemed excited. “He sounded happier than a child who was offered candy,” recalls M. Five minutes into the conversation, the sales representative threw a curveball: “Sir, at least 40% of people with haemorrhoids develop cancer in a few years and this percentage is only increasing. With your flourishing corporate career, I’m sure you don’t want to risk it!” Even as M was trying to make sense of what this …

You may also like

Internet
Story image

Eternal, Swiggy, Zepto are all unskilled worker arbitrage businesses

Exploitation of unskilled workers is at the heart of quick-delivery service businesses in India. They should be valued for what they are and not what they pretend to be, a trait that has taken a devious form of wanting it both ways.

Business
Story image

Indian consumer startups end 2025 on a high. Next year may not be so easy.

Stories of great outcomes and easy funding kept the sector on its toes. The momentum is expected to continue going into 2026, but startups may need to rethink their strategy.

Business
Story image

The weight-loss wave that’s changing India—one sector at a time

Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.